Table of Contents Table of Contents
Previous Page  15 / 63 Next Page
Information
Show Menu
Previous Page 15 / 63 Next Page
Page Background

1472

O

fitserova

& N

erkar

:

J

ournal of

AOAC I

nternational

V

ol

.

99, N

o

.

6, 2016

(

5

) 

Green tea extract tablets.—

Each tablet contained 500 mg

green tea standardized extract (175 mg epigallocatechin gallate),

calcium phosphate (47 mg calcium), stearic acid, modified

cellulose gum, and silica.

D. Preparation of Standard Solutions

(a) 

l

-Theanine stock solution (500 μg/mL).—

l

-Theanine

stock solution was prepared by weighing 50 mg

l

-theanine in a

100 mL volumetric flask and diluting to volume with extraction

solution. The final concentration was corrected for purity stated

in the certificate of analysis. The solution was stored refrigerated

for up to 8 weeks.

(b) 

IS stock solution (500 μg/mL).—

l

-Norleucine stock

solution was prepared by weighing 50 mg

l

-norleucine in a

100 mL volumetric flask and diluting to volume with extraction

solution. The final concentration was corrected to the purity

stated in Certificate of Analysis. The solution was stored

refrigerated for up to 8 weeks.

(c) 

l

-Theanine intermediate stock solution (50

 μ

g/mL).—

l

-Theanine intermediate stock solution was prepared by

pipetting 2.5 mL

l

-theanine stock solution into a 25 mL

volumetric flask and diluting to volume with extraction solution.

(d) 

Mixed working calibration solutions

.

Mixed working

calibration solutions were prepared by diluting stock solutions

of

l

-theanine and

l

-norleucine with extraction solution

according to Table

2016.10A

. All working calibration solutions

were prepared on the day of analysis.

E. Sample Preparation and Extraction

Sample size and volume of extraction solution were chosen

based on sample availability, sample type, and expected

theanine concentration.

(a) 

For samples in tablet form.—

At least 20 tablets were

finely ground and the resulting sample thoroughly mixed

before separating out the test portion. A 0.1–0.5 g portion was

accurately weighed in a 10 or 25 mL volumetric flask. IS stock

solution (500 μL) and extraction solution (20 mL) were added

to the 25 mL volumetric flask and mixed well. IS stock solution

(200 μL) and extraction solution (8 mL) were added to the

10 mL volumetric flask and mixed well. The flask was placed in

an ultrasonic water bath for 2 h. After cooling the flask to room

temperature, the solution was diluted to volume with extraction

solution and then mixed and transferred to a 50 mL centrifuge

tube. The extract was centrifuged for 20 min at 3800 rpm,

filtered through 0.45 μm syringe filter, and placed in an HPLC

autosampler vial for analysis.

(b) 

Forsamplesinpowderform.—

Thesamplewasthoroughly

mixed before separating out the test portion. A 0.1–0.5 g portion

was accurately weighed in a 10 or 25 mL volumetric flask. IS

stock solution (500 μL) and extraction solution (20 mL) were

added to the 25 mL volumetric flask and mixed well. IS stock

solution (200 μL) and extraction solution (8 mL) were added

to the 10 mL volumetric flask and mixed well. The flask was

placed in an ultrasonic water bath for 2 h. After cooling the

flask to room temperature, the solution was diluted to volume

with extraction solution and then mixed and transferred to a

50 mL centrifuge tube. The extract was centrifuged for 20 min

at 3800 rpm, filtered through 0.45 μm syringe filter, and placed

in an HPLC autosampler vial for analysis.

(c) 

For samples in liquid form.—

The sample was thoroughly

mixed before separating out the test portion. A 0.1–0.5 g portion

was accurately weighed in a 10 or 25 mL volumetric flask. IS

stock solution (500 μL) and extraction solution (20 mL) were

added to the 25 mL volumetric flask and mixed well. IS stock

solution (200 μL) and extraction solution (8 mL) were added

to the 10 mL volumetric flask and mixed well. The flask was

placed in an ultrasonic water bath for 2 h. After cooling the

flask to room temperature, the solution was diluted to volume

with extraction solution and then mixed and transferred to a

50 mL centrifuge tube. The extract was centrifuged for 20 min

at 3800 rpm, filtered through 0.45 μm syringe filter, and placed

in an HPLC autosampler vial for analysis.

(d) 

For softgels, gelcaps, or encapsulated dry supplement

samples.—

The contents of at least 15 capsules were removed

and thoroughly mixed before separating out the test portion.

A 0.1–0.5 g portion was accurately weighed in a 10 or 25 mL

volumetric flask. IS stock solution (500 μL) and extraction

solution (20 mL) were added to the 25 mL volumetric flask and

mixed well. IS stock solution (200 μL) and extraction solution

(8 mL) were added to the 10 mL volumetric flask and mixed

well. The flask was placed in an ultrasonic water bath for 2 h.

After cooling the flask to room temperature, the solution was

diluted to volume with extraction solution and then mixed

and transferred to a 50 mL centrifuge tube. The extract was

centrifuged for 20 min at 3800 rpm, filtered through 0.45 μm

syringe filter, and placed in an HPLC autosampler vial for

analysis.

(e) 

For SRMs.—

A 0.1 g sample was accurately weighed in

a 10 or 25 mL volumetric flask. IS stock solution (500 μL) and

extraction solution (20 mL) were added to the 25 mL volumetric

flask and mixed well. IS stock solution (200 μL) and extraction

solution (8 mL) were added to the 10 mL volumetric flask and

mixed well. The flask was placed in an ultrasonic water bath for

2 h. After cooling the flask to room temperature, the solution was

diluted to volume with extraction solution and then mixed and

transferred to a 50mLcentrifuge tube. The extract was centrifuged

for 20 min at 3800 rpm, filtered through 0.45 μm syringe filter,

and placed in an HPLC autosampler vial for analysis.

F. Safety

Postcolumn ninhydrin reagent (Trione) is sensitive to

oxidation, so reagent bottles were pressurized with nitrogen at

5 psi. Safety-coated bottles were used to hold the postcolumn

reagent.

Table 2016.10A. Preparation of mixed working calibration

solutions

Volume of

l-theanine

stock

solution, mL

Volume of

l-norleucine

stock solution,

mL

Total volume

of calibration

solution, mL

l-Theanine

concn, μg/mL

l-Norleucine

concn, μg/mL

2.00

0.5

25

40

10

1.250

0.5

25

25

10

0.500

0.5

25

10

10

0.374

0.5

25

7.48

10

0.250

0.5

25

5

10

0.125

0.5

25

2.5

10

0.050

0.5

25

1

10

15